LWM
HUMA icon

LJI Wealth Management’s Humacyte HUMA Stock Holding History

LJI Wealth Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Sell
269,500
-8,000
-3% -$7.41K 0.03% 193
2026
Q1 		$168K Sell
277,500
-31,000
-10% -$32.2K 0.03% 187
2025
Q4 		$296K Sell
308,500
-7,500
-2% -$10.6K 0.05% 163
2025
Q3 		$550K Buy
316,000
+28,000
+10% +$54.9K 0.1% 81
2025
Q2 		$602K Buy
288,000
+62,000
+27% +$119K 0.1% 78
2025
Q1 		$385K Buy
226,000
+41,000
+22% +$154K 0.08% 107
2024
Q4 		$934K Buy
+185,000
New +$915K 0.18% 50

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LJI Wealth Management's HUMA Position: Q2 2026 in Review

LJI Wealth Management reduced its Humacyte (HUMA) stake by 2.9% in Q2 2026, selling an estimated $7.41K and leaving 269,500 shares worth $210K. The position accounts for 0.03% of the portfolio, ranked #193.

LJI Wealth Management first reported a position in HUMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $934K in Q4 2024. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • LJI Wealth Management held 269,500 shares of Humacyte worth $210K as of Q2 2026.
  • LJI Wealth Management sold 8,000 Humacyte shares in Q2 2026, an estimated $7.41K.
  • Humacyte made up 0.03% of LJI Wealth Management's portfolio in Q2 2026, its #193 holding.
  • LJI Wealth Management first reported a position in Humacyte in Q4 2024 and has held it in 7 quarters since.
  • LJI Wealth Management's Humacyte position peaked at $934K in Q4 2024.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on LJI Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.